Otsuka’s Sibeprenlimab Shows Significant Proteinuria Reduction in IgAN Phase 3 Trial Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) today presented results from a pre-specified interim analysis of the Phase 3 VISIONARY study (NCT05248646) evaluating sibeprenlimab,…
Simplify Healthcare, a recognized leader in enterprise software solutions for Payers, proudly announces that its flagship platform, Benefits1™.Medicare, played a key role once again in streamlining over 30% of Medicare Advantage (MA) Plan Benefit Package (PBP) submissions to the Centers for Medicare &…
MDP Completes Acquisition of Significant Ownership Position in NextGen Healthcare and Partners with Thoma Bravo and Company Management to Accelerate NextGen Healthcare’s Growth NextGen Healthcare President and COO Srinivas (Sri) Velamoor will Succeed David Sides as CEO after Planned Transition…
The “Companion Diagnostic Markets 2025-2029: The Future of Diagnostics by Application, Technology and Funding with Executive & Consultant Guides” report has been added to ResearchAndMarkets.com’s offering. Companion Diagnostics are changing the diagnostics industry. Whole new markets are emerging. Diagnostic and Therapeutic partnerships. Find out…
-Global IT services provider FPT and Pharma Group jointly hosted the Healthcare Innovation Forum – HIF 2025. The event served as a multi-stakeholder dialogue platform with a spotlight on breakthrough innovations in science, technology, and AI to accelerate healthcare advancements…
Quantum Health (“Quantum”), the creator of healthcare navigation, has signed a definitive agreement to acquire Embold Health (“Embold”), a leading physician-led healthcare technology company. The transaction is expected to close within the next 14 days, subject to customary closing conditions and…
Altera Digital Health, a global healthcare IT leader, today announced it has entered into an agreement with Managed Care Advisory Group, Inc. (MCAG), one of the largest revenue recovery consulting firms, to bring MCAG’s class action lawsuit recovery services to hospitals and…
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it has initiated the process with the U.S. Centers for Medicare and Medicaid Services (CMS) to seek reconsideration of national Medicare coverage for VNS Therapy™ in unipolar patients with…
TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies and our investigational immunotherapy, is excited to announce the launch of…
SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today announced the appointment of Tyler Binney to its Board of Directors. With a career built around scaling disruptive MedTech platforms, Binney brings over two decades…
Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, announces that Blue Cross and Blue Shield of Louisiana (BCBSLA) has added Kerecis MariGen® to its list of covered treatments for diabetic foot…
-Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of…